Publications by authors named "Edward Cabral"

Claim this Profile
1
18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.
Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang, Laigao Chen, Feng Liu, Edward Cabral

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, Malgorzata Nocula-Lugowska, Lioudmila Tchistiakova, Edward Cabral

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Positron Emission Tomography with Body Conforming Animal Molds for Cloud-Based Automated Image Analysis in Mice.
Edward Cabral, Mary Katherine Montgomery, Meaghan Berg, Lisa Kathryn Manzuk, Anand Giddabasappa

J Vis Exp· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon regulation by USP18 is a key vulnerability in cancer.
Veronica Jové, Heather Wheeler, Chiachin Wilson Lee, David R Healy, Kymberly Levine, Edward Cabral

iScience· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys.
Dean O Campbell, Akihiro Noda, Alla Verlinsky, Josh Snyder, Yuji Fujita, Edward Cabral

Mol Imaging Biol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis